Tim Scott actually said...

It is amazing the impact that the disease has not only on the patient but on the family and on the loved ones.

I cannot think of anyone here on this panel who has not been impacted personally by Alzheimer's.

The pace of that progress is being limited by the amount of research that we can support.

I think Regions, in particular, talked about how their regulatory burden from a cost perspective is around $200 million.